Microelectronic Medical Implants: Products, Technologies & Opportunities
The global market for microelectronic medical implants should reach over $37.6 billion in 2021 from over $24.6 billion in 2016 at a compound annual growth rate (CAGR) of 8.8% from 2016 to 2021.
- An overview of the global markets and technologies for microelectronic medical implants.
- An analysis of global market trends, with data from 2015, 2016 and projections of compound annual growth rates (CAGRs) through 2021.
- Major implant types and applications, both commercial and developmental.
- Global market size and segmentation, including historical data on sales by application and implant type.
- Market drivers and constraints.
- A look at industry structure, competition and market shares.
- Factors that may influence the long-term market for microelectronic implants.
- Profiles of major players in the industry.
This report covers microelectronic devices designed to operate within the human body, including:
- Implantable cardioverter defibrillators (ICDs).
- Implantable loop recorders.
- Ventricular assist blood pumps.
- Artificial hearts.
- Neurostimulator devices used to combat pain or to treat epilepsy, Parkinson’s disease and incontinence.
- Spinal fusion stimulators.
- Implanted drug infusion pumps.
- Implanted monitoring devices.
- Cochlear implants to treat the profoundly deaf.
- Retinal implants being developed to treat the blind.
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
The global market for microelectronic medical implants, accessories, and supplies was worth an estimated $15.4 billion in 2010. The market is projected to grow to $16.3 billion in 2011 and $24.8 billion in 2016, a compound annual growth rate (CAGR) of 8.8%, between 2011 and 2016.
The global market for microelectronic medical implants was worth an estimated $11.7 billion in 2006. The market is projected to grow to $12.6 billion in 2007 and $22.1 billion in 2012 at a CAGR of 11.9% from 2007 to 2012.
Cardiac implants were by far the largest market segment in 2006, accounting for more than three-quarters of total implant sales. Neurostimulators were the second largest market segment, with about 9% of the market, followed by accessories such as leads and electrodes, with a 7% market share. executive summary (Continued)
However, the market for neurostimulators is projected to grow over twice as fast as the market for cardiac implants from 2007 to 2012, that is, at a CAGR of 20% vs. 10% respectively.
The global market for microelectronic medical implants is projected to be $11.9 billion in 2004 and to rise at an average annual growth rate (AAGR) of 22.1% to $32.3 billion in 2009.
Cardiac implants by far were the largest market segment in 2003, with sales of $7.2 billion, or more than three-quarters of total sales.
Neurostimulators were the second largest market segment, with sales of $944 million, but are projected to grow at an AAGR of 39.7%, more than double that of cardiac implants (18.4%).
The AAGR for accessories and supplies (27.5%) also is expected to outstrip growth of the market as a whole. The slowest-growing market segments likely will be spinal fusion stimulators and implantable drug pumps.
- Eye implants are unlikely to see any commercial sales before 2009.